contadores web
Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Control and management of health risks and emergencies

Vol. 25 No. 2 (2023)

Synopsis of systematic reviews on the clinical effect of Ketamine in the agitated patient

DOI
https://doi.org/10.22267/rus.232502.291
Submitted
March 8, 2021
Published
2023-04-28

Abstract

Introduction: The scientific literature about Ketamine use shows high heterogeneity in terms of design, populations, outcomes, and clinical specialties. Nevertheless, available evidence systematically consolidated to guide clinical decisions for anxious patients was not found. Objective: To analyze evidence available in systematic reviews about the use of Ketamine in anxious patients. Materials and methods: Systematic search in multidisciplinary databases. The “A measurement Tool to Assess Systematic Reviews-2” was used to guarantee comprehensiveness of the searching protocol and study selection, reproducibility, and analysis of the methodological quality. A quantitative synthesis of the extracted variables and proportion estimation with a 95% CI were performed. Results: 10 out of 134 screened studies met the protocol criteria. The systematic reviews included a population of 26,936 patients and the evidence comes mainly from two case series, 7 observational studies, and 9 controlled clinical trials. Ketamine has multiple adverse effects, some of them more critical than those caused by Midazolam. Conclusion: Some patient subgroups showed a high frequency of adverse effects such as respiratory, neuropsychiatric, and cardiovascular dysfunctions, but it was difficult to generalize them to other contexts. It is necessary to improve clinical and epidemiological evidence in order to prescribe Ketamine to manage anxiety.

References

  1. Holloman G, Zeller S. Overview of Project BETA: Best Practices in Evaluation and Treatment of Agitation. West J Emerg Med. 2012;13(1):1–2. DOI: 10.5811/westjem.2011.9.6865
  2. Wilson M, Pepper D, Currier G, Holloman G, Feifel D. The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. West J Emerg Med. 2012;13(1):26–34. DOI: 10.5811/westjem.2011.9.6866
  3. Casado Flórez IC, Sánchez Santos LS, Rodríguez Calzada RR, Rico-Villademoros F, Roset Arissó PR, Corral Torres EC. Incidencia y variabilidad de manejo de la agitación aguda en los servicios de emergencias médicas. Emergencias. 2017;29(4):253-256. Disponible en: https://medes.com/publication/123769
  4. Sheikh S, Hendry P. The Expanding Role of Ketamine in the Emergency Department. Drugs. 2018;78(7):727–735. DOI: 10.1007/s40265-018-0904-8
  5. Riddell J, Tran A, Bengiamin R, Hendey GW, Armenian P. Ketamine as a first-line treatment for severely agitated emergency department patients. Am J Emerg Med. 2017;35(7):1000–1004. DOI: 10.1016/j.ajem.2017.02.026
  6. Li L, Vlisides PE. Ketamine: 50 Years of Modulating the Mind. Front Hum Neurosci [Internet]. 2016 Nov 29 [cited 2020 Oct 26];10:612. Disponible en: http://journal.frontiersin.org/article/10.3389/fnhum.2016.00612/full
  7. MacEntee MI. A typology of systematic reviews for synthesising evidence on health care. Gerodontology. 2019;36(4):303–312. DOI: 10.1111/ger.12439
  8. Baird R. Systematic reviews and meta-analytic techniques. Semin Pediatr Surg. 2018;27(6):338–344. DOI: 10.1053/j.sempedsurg.2018.10.009
  9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol. 2009;62(10):1006–1012. DOI: 10.1016/j.jclinepi.2009.06.005
  10. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. DOI: 10.1136/bmj.j4008
  11. McGirr A, Berlim MT, Bond DJ, Neufeld NH, Chan PY, Yatham LN, et al. A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: Efficacy and tolerability. J Psychiatr Res. 2015;62:23–30. DOI: 10.1016/j.jpsychires.2015.01.003
  12. McCloud TL, Caddy C, Jochim J, Rendell JM, Diamond PR, Shuttleworth C, et al. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Cochrane Database Syst Rev. 2015 Sep 29;(9):CD011611. DOI: 10.1002/14651858.CD011611.pub2
  13. Bellolio MF, Gilani WI, Barrionuevo P, Murad MH, Erwin PJ, Anderson JR, et al. Incidence of Adverse Events in Adults Undergoing Procedural Sedation in the Emergency Department: A Systematic Review and Meta-analysis Acad Emerg Med. 2016 Feb;23(2):119-134. DOI: 10.1111/acem.12875
  14. Bellolio MF, Puls HA, Anderson JL, Gilani WI, Murad MH, Barrionuevo P, et al. Incidence of adverse events in paediatric procedural sedation in the emergency department: a systematic review and meta-analysis. BMJ Open. 2016;6(6):e011384. DOI: 10.1136/bmjopen-2016-011384
  15. Shi J, Li A, Wei Z, Liu Y, Xing C, Shi H, et al. Ketamine versus ketamine pluses atropine for pediatric sedation: A meta-analysis. Am J Emerg Med. 2018;36(7):1280–1286. DOI: 10.1016/j.ajem.2018.04.010
  16. Mankowitz SL, Regenberg P, Kaldan J, Cole JB. Ketamine for Rapid Sedation of Agitated Patients in the Prehospital and Emergency Department Settings: A Systematic Review and Proportional Meta-Analysis. J Emerg Med. 2018;55(5):670-681. DOI: 10.1016/j.jemermed.2018.07.017
  17. Sullivan N, Chen C, Siegel R, Ma Y, Pourmand A, Montano N, et al. Ketamine for emergency sedation of agitated patients: A systematic review and meta-analysis. Am J Emerg Med. 2020;38(3):655–661. DOI: 10.1016/j.ajem.2019.11.007
  18. Kim S, Rush BS, Rice TR. A systematic review of therapeutic ketamine use in children and adolescents with treatment-resistant mood disorders. Eur Child Adolesc Psychiatry. 2021 Oct;30(10):1485-1501. DOI: 10.1007/s00787-020-01542-3
  19. Beck K, Hindley G, Borgan F, Ginestet C, McCutcheon R, Brugger S, et al. Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(5):e204693. DOI: 10.1001/jamanetworkopen.2020.4693
  20. Manasco AT, Stephens RJ, Yaeger LH, Roberts BW, Fuller BM. Ketamine sedation in mechanically ventilated patients: A systematic review and meta-analysis. J Crit Care. 2020;56:80-88. DOI: 10.1016/j.jcrc.2019.12.004
  21. Gerson R, Malas N, Mroczkowski MM. Crisis in the Emergency Department: The Evaluation and Management of Acute Agitation in Children and Adolescents. Child Adolesc Psychiatr Clin N Am. 2018 Jul;27(3):367-386. DOI: 10.1016/j.chc.2018.02.002
  22. Gerson R, Malas N, Feuer V, Silver GH, Prasad R, Mroczkowski MM. Best Practices for Evaluation and Treatment of Agitated Children and Adolescents (BETA) in the Emergency Department: Consensus Statement of the American Association for Emergency Psychiatry. West J Emerg Med. 2019 Mar;20(2):409-418. DOI: 10.5811/westjem.2019.1.41344

Downloads

Download data is not yet available.